1. Clinical and Translational Radiation Oncology
Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study 
Theodora A. Koulis, Elizabeth N. Kornaga, Robyn Banerjee, Tien Phan, Prafull Ghatage, Anthony M. Magliocco, Susan P. Lees-Miller, Corinne M. Doll 
Clinical and Translational Radiation Oncology 
Volume 4, Pages (June 2017)
DOI: /j.ctro
Copyright © 2017 The Authors Terms and Conditions

2. Fig. 1
5-year PFS (A) and OS (B) for patients with Hgb levels >115g/L (high Hgb) vs patients with both anemia and leukocytosis.
Clinical and Translational Radiation Oncology 2017 4, 51-56DOI: ( /j.ctro )
Copyright © 2017 The Authors Terms and Conditions

3. Fig. 2
5-year PFS (A) and OS (B) for patients with Hgb levels >115g/L (high Hgb) vs patients with both anemia and elevated NLR.
Clinical and Translational Radiation Oncology 2017 4, 51-56DOI: ( /j.ctro )
Copyright © 2017 The Authors Terms and Conditions

4. Fig. 3
5-year PFS (A) and OS (B) comparing patient’s Hgb status throughout treatments: Hgb levels >115g/L both pre- and during-treatment (HH group), normal pre-treatment and low during treatment (HL group), low pre-treatment and normal during treatment (LH group), and low both pre- and during-treatment (LL group).
Clinical and Translational Radiation Oncology 2017 4, 51-56DOI: ( /j.ctro )
Copyright © 2017 The Authors Terms and Conditions